Senior Financial Analyst, US Innovative Medicine, Gross-to-Net
$79,000–$127,650 year
Hybrid · Titusville, New Jersey, United States
Job Summary
Senior Financial Analyst for Gross-to-Net in US Innovative Medicine. Responsible for financial leadership and business partner support across Gross-to-Net for a portion of the Established Products Group portfolio, including channel responsibilities for ADAP, Cash Discounts, and Returns Reserve. Influence GTN forecasting and actuals, support quarterly close activities, and present results to senior leaders. Develop review materials, provide clear visibility into quarterly fluctuations, and drive process improvements to increase efficiency and forecast accuracy. Collaborate across Finance, Brand Management, Pricing Strategy, Business Analytics, and Government Contract Compliance; travel up to 10% as needed.
Required Qualifications
- Bachelor’s degree in Finance or Accounting required; MBA, CPA, CMA or other financial certifications preferred
- Minimum of 3 years finance experience required
- Experience in pharmaceutical/medical device/consumer products industry preferred
- Excellent analytical, communication, and interpersonal skills; ability to work in a team and lead initiatives
- Ability to work in a dynamic environment, manage multiple tasks, and implement process improvements
Apply with one swipe on Sorce. We auto-fill applications and apply on your behalf — no cover letters, no 40-minute forms.
Hiring someone like this?
Get your role in front of qualified candidates on Sorce.